OFFICIAL PUBLICATION OF

by its subsidiary APPco

APP2021 APP2021 News APP2021 Videos

Talking pharmacy

02/06/2021

Angelo Pricolo discusses the latest developments with naloxone therapy, and talks about the inspiration for his popular AJP columns Regular AJP contributor Angelo Pricolo talks to AJP editor Chris Brooker about the latest developments with naloxone provision in pharmacy, and also lets us know where he gets the inspiration for his popular columns.

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Should nicotine vaping products go S3?

“ and he is not convinced that pharmacists would be able to sufficiently gatekeep the use of NVPs for reasons…

John Smith

Transaction fees drive MedAdvisor growth

I agree . I don’t think we should be charged for using a program like Project Stop . There should…

geoffrey colledge

Transaction fees drive MedAdvisor growth

An 89% gross margin? Wow. That's just staggering considering the lack of service and reliability.

Marion Crowther

Transaction fees drive MedAdvisor growth

Why are other software providers - like Z-software not able to introduce a competing system ? Monopolies breed inefficiency.

Robert Smith

Talking pharmacy

Previous ‘Pharmacists can and need to make a difference.’

Next Focused on work ahead as Reconciliation Week ends

Clinical tips: Timing!

Clinical tips: Movement disorders

Clinical tips: Worms, Worms, Worms

Intranasal Midazolam for at home use

MENU

Previous ‘Pharmacists can and need to make a difference.’

Next Focused on work ahead as Reconciliation Week ends

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.